# A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis

> **NCT04881461** · PHASE3 · COMPLETED · sponsor: **ALK-Abelló A/S** · enrollment: 445 (actual)

## Conditions studied

- Allergy

## Interventions

- **DRUG:** 5-grass mix SLIT-drops
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04881461
- **Lead sponsor:** ALK-Abelló A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-10
- **Primary completion:** 2023-09-26
- **Final completion:** 2023-09-26
- **Target enrollment:** 445 (ACTUAL)
- **Last updated:** 2024-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04881461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04881461, "A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04881461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*